Sanofi said SAR446597, its treatment for geographic atrophy due to age-related macular degeneration, was granted fast-track designation by the Food and Drug Administration.

Higher education appeared to protect against tau accumulation during the amyloid-negative stages of Alzheimer's disease but was associated with accelerated tau accumulation in amyloid-positive stages, ...